Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04940637
Title UNITO-001-A Phase II Study Niraparib Plus Dostarlimab in HRR/PDL1 Positive MPM/NSCLC (UNITO-001)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Turin, Italy
Indications

malignant pleural mesothelioma

lung non-small cell carcinoma

Therapies

Dostarlimab-gxly + Niraparib

Age Groups: senior | adult
Covered Countries

Additional content available in CKB BOOST